You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 7,504,095


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,504,095 protect, and when does it expire?

Patent 7,504,095 protects NULIBRY and is included in one NDA.

This patent has ten patent family members in ten countries.

Summary for Patent: 7,504,095
Title:Method for obtaining precursor Z and use thereof for the production of a means for therapy of human molybdenum cofactor deficiency
Abstract: The invention relates to a method for obtaining the molybdopterin derivative precursor Z, wherein an over-production of precursor Z occurs in host organisms by recombinant expression of precursor Z synthesizing proteins. The invention further relates to the use of precursor Z for the production of a means for the therapy of human molybdenum cofactor deficiency and associated diseases, which may be directly or indirectly attributed to an altered molybdenum cofactor synthesis, whereby precursor Z is used as essential component of said therapy means.
Inventor(s): Schwarz; Guenter (Niederkassel, DE), Mendel; Ralf (Leitferde, DE), Santamaria; Jose (Koln, DE), Reiss; Jochen (Niemetal, DE)
Assignee: Technische Universitaet Braunschweig (Braunschweig, DE)
Application Number:11/343,489
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,504,095: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 7,504,095, providing a detailed analysis of its scope, claims, and the broader patent landscape.

Patent Basics

Before diving into the specifics of US Patent 7,504,095, it is essential to understand the basics of patents. A patent is a form of intellectual property that grants the owner the exclusive right to make, use, sell, and distribute the invention for a specified period, usually 20 years from the filing date[5].

Patent 7,504,095 Overview

To analyze the scope and claims of US Patent 7,504,095, one must first identify the patent's title, inventors, assignees, and the technology field it pertains to. Here is a general outline:

  • Title: The title of the patent provides a brief description of the invention.
  • Inventors: The names of the individuals who created the invention.
  • Assignees: The entities to which the patent rights have been assigned.
  • Technology Field: The broad category under which the invention falls, such as electrical, mechanical, or chemical.

Patent Claims

The claims section of a patent is the most critical part as it defines the scope of the invention. Here’s how to analyze the claims:

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. They are typically broader and more general.

Dependent Claims

Dependent claims refer back to an independent claim and further limit the scope of the invention. They often add specific details or features to the independent claims.

Claim Construction

Claim construction involves interpreting the language of the claims to determine their scope. This process is crucial in patent litigation and can significantly impact the enforceability of the patent[4].

Scope of the Invention

The scope of the invention is determined by the claims, but it is also influenced by the description and drawings provided in the patent specification.

Description and Drawings

The description and drawings provide detailed explanations and visual representations of the invention. These elements help in understanding how the invention works and its various components.

Prior Art and Novelty

To ensure the patent's validity, it is essential to compare the invention with prior art. The patent must be novel and non-obvious over existing technologies to be granted[5].

Patent Landscape

Understanding the patent landscape involves analyzing related patents and patent applications in the same technology field.

Global Dossier

Tools like the Global Dossier provided by the USPTO allow users to see the patent family for a specific application, including related applications filed at participating IP Offices. This helps in identifying similar inventions and potential competitors[1].

Common Citation Document (CCD)

The CCD consolidates prior art cited by all participating offices for the family members of a patent application. This tool is invaluable for understanding the global citation landscape and ensuring that the invention is unique[1].

Economic Value of Patents

Patents can have significant economic value, as evidenced by various high-profile patent deals.

Historical Deals

For example, in 2011, Rockstar Bidco, a consortium including Apple, BlackBerry, Ericsson, Microsoft, and Sony, paid $4.5 billion for 6,000 patent documents from Nortel. This deal highlights the substantial value that patents can hold in the market[2].

Valuation Metrics

The value of a patent can be estimated using various metrics, including the asking price per document, per US patent, and per patent family. These metrics provide a baseline for understanding the financial implications of patent ownership[2].

Allowance Rates and Examination Process

The probability of receiving a patent is influenced by several factors, including the technology field and the type of entity filing the application.

Allowance Rates

Studies have shown that applications filed by large firms are more likely to be granted than those filed by small firms. The allowance rates vary across different technology fields, with some fields having higher success rates than others[4].

Continuation Procedures

Continuation procedures, such as Request for Continued Examination (RCE) and Continuation-in-Part (CIP), can affect the outcome of patent applications. These procedures allow applicants to address examiner objections and introduce new subject matter, potentially increasing the chances of patent grant[4].

Public Search and Resources

Access to patent information is crucial for conducting thorough analyses.

USPTO Public Search Facility

The USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) provide public access to patent and trademark information. These resources are invaluable for inventors and researchers[1].

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset offers detailed information on claims from U.S. patents and applications, which can be used to analyze patent scope and trends[3].

Key Takeaways

  • Patent Claims: The claims section is the most critical part of a patent, defining the scope of the invention.
  • Scope of the Invention: Determined by the claims, description, and drawings.
  • Patent Landscape: Analyzing related patents and applications is essential for understanding the competitive environment.
  • Economic Value: Patents can hold significant economic value, as seen in historical deals.
  • Allowance Rates: Vary across technology fields and entity types.
  • Public Resources: Utilize USPTO facilities and datasets for comprehensive patent research.

FAQs

Q: What is the primary purpose of the claims section in a patent?

A: The claims section defines the scope of the invention and determines what is protected by the patent.

Q: How can I determine the scope of an invention?

A: The scope is determined by the claims, description, and drawings provided in the patent specification.

Q: What is the Global Dossier, and how is it useful?

A: The Global Dossier is a service that provides access to the file histories of related applications from participating IP Offices, helping users to see the patent family and related applications.

Q: What factors influence the probability of receiving a patent?

A: Factors include the technology field, type of entity filing the application, and continuation procedures.

Q: Where can I find detailed information on patent claims and scope?

A: The USPTO's Patent Claims Research Dataset and other public search facilities provide comprehensive data on patent claims and scope.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Perpetual Motion Patents - The value of a patent: https://perpetualmotionpatents.com/the-value-of-a-patent/
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Yale Journal of Law and Technology - What Is the Probability of Receiving a US Patent?: https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  5. USPTO - Patents: https://www.uspto.gov/patents

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,504,095

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sentynl Theraps Inc NULIBRY fosdenopterin hydrobromide POWDER;INTRAVENOUS 214018-001 Feb 26, 2021 RX Yes Yes 7,504,095 ⤷  Subscribe Y METHOD OF TREATING MOLYBDENUM COFACTOR DEFICIENCY TYPE A ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,504,095

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany10 2004 004 642Jan 29, 2004
Germany10 2004 063 948Jan 30, 2004

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.